These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30516111)

  • 1. Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe?
    Zhang Z; Wen H; Yang X; Zhang K; He B; Zhang X; Kong L
    Curr Stem Cell Res Ther; 2019; 14(3):239-243. PubMed ID: 30516111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.
    Ozaki K; Yamada T; Horie T; Ishizaki A; Hiraiwa M; Iezaki T; Park G; Fukasawa K; Kamada H; Tokumura K; Motono M; Kaneda K; Ogawa K; Ochi H; Sato S; Kobayashi Y; Shi YB; Taylor PM; Hinoi E
    Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
    Chen W; Zhu G; Tang J; Zhou HD; Li YP
    J Pathol; 2018 Mar; 244(3):271-282. PubMed ID: 29083488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.
    Kuroda Y; Hisatsune C; Mizutani A; Ogawa N; Matsuo K; Mikoshiba K
    Mol Cell Biol; 2012 Jul; 32(14):2954-63. PubMed ID: 22615493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition.
    Yuan L; Zhao N; Wang J; Liu Y; Meng L; Guo S; Wiemer EAC; Chen Q; Mao Y; Ben J; Ma J
    Theranostics; 2021; 11(15):7247-7261. PubMed ID: 34158848
    [No Abstract]   [Full Text] [Related]  

  • 7. RCANs regulate the convergent roles of NFATc1 in bone homeostasis.
    Kim JH; Kim K; Kim I; Seong S; Jeong BC; Nam KI; Kim KK; Molkentin JD; Kim N
    Sci Rep; 2016 Dec; 6():38526. PubMed ID: 27917924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Wnt signals in bone resorption during physiological and pathological states.
    Maeda K; Takahashi N; Kobayashi Y
    J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription.
    Yang Y; Chung MR; Zhou S; Gong X; Xu H; Hong Y; Jin A; Huang X; Zou W; Dai Q; Jiang L
    J Biol Chem; 2019 Oct; 294(42):15395-15407. PubMed ID: 31462535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway.
    Noguchi T; Ebina K; Hirao M; Otsuru S; Guess AJ; Kawase R; Ohama T; Yamashita S; Etani Y; Okamura G; Yoshikawa H
    Biochem Biophys Res Commun; 2018 Sep; 503(2):644-650. PubMed ID: 29906458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eIF2α signaling regulates autophagy of osteoblasts and the development of osteoclasts in OVX mice.
    Li J; Li X; Liu D; Hamamura K; Wan Q; Na S; Yokota H; Zhang P
    Cell Death Dis; 2019 Dec; 10(12):921. PubMed ID: 31801950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
    Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
    Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.
    Thaler R; Maurizi A; Roschger P; Sturmlechner I; Khani F; Spitzer S; Rumpler M; Zwerina J; Karlic H; Dudakovic A; Klaushofer K; Teti A; Rucci N; Varga F; van Wijnen AJ
    J Biol Chem; 2016 Mar; 291(13):6754-71. PubMed ID: 26757819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
    He L; Lee J; Jang JH; Lee SH; Nan MH; Oh BC; Lee SG; Kim HH; Soung NK; Ahn JS; Kim BY
    Bone; 2012 Jun; 50(6):1207-13. PubMed ID: 22484180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin/NFAT signaling in osteoblasts regulates bone mass.
    Winslow MM; Pan M; Starbuck M; Gallo EM; Deng L; Karsenty G; Crabtree GR
    Dev Cell; 2006 Jun; 10(6):771-82. PubMed ID: 16740479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PU.1 in NFATc1 promoter function in osteoclast development.
    Ishiyama K; Yashiro T; Nakano N; Kasakura K; Miura R; Hara M; Kawai F; Maeda K; Tamura N; Okumura K; Ogawa H; Takasaki Y; Nishiyama C
    Allergol Int; 2015 Jul; 64(3):241-7. PubMed ID: 26117255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.